News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
652,473 Results
Type
Article (46140)
Company Profile (282)
Press Release (606051)
Section
Business (188507)
Career Advice (2571)
Deals (33922)
Drug Delivery (109)
Drug Development (80574)
Employer Resources (158)
FDA (15990)
Job Trends (14743)
News (327472)
Policy (32237)
Tag
Academia (2749)
Alliances (48117)
Alzheimer's disease (1288)
Approvals (15902)
Artificial intelligence (152)
Bankruptcy (331)
Best Places to Work (11432)
Biotechnology (166)
Breast cancer (123)
Cancer (1128)
Cardiovascular disease (106)
Career advice (2153)
Cell therapy (245)
Clinical research (64068)
Collaboration (403)
Compensation (146)
COVID-19 (2585)
C-suite (104)
Data (1123)
Diabetes (161)
Diagnostics (6112)
Drug pricing (98)
Earnings (69757)
Employer resources (142)
Events (98849)
Executive appointments (324)
FDA (16521)
Funding (356)
Gene therapy (190)
GLP-1 (655)
Government (4461)
Healthcare (18263)
Infectious disease (2676)
Inflammatory bowel disease (109)
Interviews (526)
IPO (15009)
Job creations (3685)
Job search strategy (1787)
Layoffs (437)
Legal (7433)
Lung cancer (186)
Manufacturing (188)
Medical device (12884)
Medtech (12889)
Mergers & acquisitions (18991)
Metabolic disorders (453)
Neuroscience (1586)
NextGen Class of 2024 (6439)
Non-profit (4475)
Northern California (1386)
Obesity (260)
Opinion (227)
Patents (109)
People (57191)
Pharmaceutical (95)
Phase I (19756)
Phase II (28185)
Phase III (21290)
Pipeline (463)
Postmarket research (2578)
Preclinical (8197)
Radiopharmaceuticals (248)
Rare diseases (229)
Real estate (5698)
Regulatory (21687)
Research institute (2434)
Resumes & cover letters (385)
Southern California (1225)
Startups (3479)
United States (12917)
Vaccines (551)
Weight loss (208)
Date
Today (127)
Last 7 days (803)
Last 30 days (3754)
Last 365 days (35463)
2024 (32482)
2023 (39368)
2022 (50124)
2021 (54413)
2020 (53070)
2019 (46642)
2018 (35364)
2017 (32522)
2016 (31724)
2015 (36761)
2014 (29341)
2013 (24433)
2012 (26158)
2011 (26785)
2010 (24231)
Location
Africa (853)
Arizona (139)
Asia (40901)
Australia (7330)
California (3118)
Canada (1258)
China (250)
Colorado (149)
Connecticut (145)
Europe (89252)
Florida (449)
Georgia (115)
Illinois (341)
Indiana (210)
Maryland (569)
Massachusetts (2445)
Michigan (159)
Minnesota (272)
New Jersey (938)
New York (935)
North Carolina (716)
Northern California (1386)
Ohio (138)
Pennsylvania (789)
South America (1189)
Southern California (1225)
Texas (450)
Washington State (341)
652,473 Results for "innovation pharma formerly known as cellceutix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Astellas Pharma Opens Cambridge Life Sciences Center Featuring Incubator Space
Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.
September 6, 2024
·
1 min read
·
Angela Gabriel
Genetown
Nxera Pharma joins the World Orphan Drug Alliance
Nxera Pharma Co. Ltd – formerly known as Sosei Group or Sosei Heptares – announces it has joined the World Orphan Drug Alliance, a global alliance of commercial distributors dedicated to providing access to treatments for rare diseases and specialty medicines in complex markets around the world.
April 8, 2024
·
4 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
Angelini Pharma Enters Into An Exclusive Option Agreement With Cureverse to License Global Development and Commercialization Rights For A Novel and Innovative Clinical-Stage Brain Health Asset
October 21, 2024
·
7 min read
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Business
FSD Pharma provides Corporate Update
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (“FSD Pharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions is pleased to provide the following corporate update.
June 28, 2024
·
10 min read
Press Releases
UroGen Pharma to Present at the Guggenheim Securities Healthcare Innovation Conference
November 5, 2024
·
1 min read
Mergers & acquisitions
Broken Deals: 4 Pharma Assets Returned to Biotech This Year
Not all licensing deals are successful. Here,
BioSpace
examines a few noteworthy assets that Big Pharma returned in the last 12 months.
August 27, 2024
·
5 min read
·
Mollie Barnes
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
November 19, 2024
·
6 min read
1 of 65,248
Next
